Journal of Innovation in Cardiac Rhythm Management

Latest News

shadow-div-content

Yiling Pharmaceutical’s Shensong Yangxin Capsules Have Obtained Registration in Nigeria—Study Has Shown that It Significantly Improves the Prognosis of Patients After Radiofrequency Ablation

Read more...

Cadrenal Therapeutics Highlights Additional Need for a New Vitamin K Antagonist (Tecarfarin) Following Updates from the Recent European Society of Cardiology Congress

Read more...

Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting the Process For Bringing Ultra-Low-Temperature Cryoablation for Ventricular Arrhythmias to US Market

Read more...

BIOTRONIK, INC. Announces First US Implant of Next-Generation Amvia Edge Pacemaker

Read more...

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device

Read more...

More Articles...